Active Studies

The primary objective of this study is to evaluate several interventions given to participants with severe asthma. Interventions are administered in a crossover manner with 16-week treatment periods followed by 8 to 16-week washout. Treatment sequence will be randomly assigned as either test treatment followed by matching placebo or vice-versa.


A multi-center, randomized, 36-month, parallel- group, non-inferiority, phase III study to compare the effectiveness of roflumilast (Daliresp, 500 mcg quaque die (QD) or alternate regimen) therapy versus azithromycin (250 mg QD, 500 mg QD three times per week, or alternate regimen) to prevent hospitalization or death in a patients at high risk for COPD exacerbations.

For older adults (greater or equal to 65 years old) who experienced a flood or extreme heat event in the past 10 years (2010-2020).

This study involves completing an online survey that will take 5-10 minutes. 

1. Describe the environmental hazards encountered from a flood and/or extreme heat event.

2. Determine the health impacts from a floods and/or extreme heat. 

The goal of this clinical research study is to learn if Niraparib can help to control metastatic pancreatic cancer. The safety of this drug will also be studied. Niraparib is FDA approved and commercially available for the treatment of ovarian cancer. Its use in this study is investigational.

Our study is interested in understanding how individuals with Autism Spectrum Disorder (ASD) and healthy individuals perform on tests of thinking and motor skills and how their brains may act differently during these kinds of tests.


 If you're interested in participating, please click this link to fill out our online screener: